Show simple item record

dc.contributor.authorHenry, Rebecca J.
dc.contributor.authorKerr, Daniel M.
dc.contributor.authorFlannery, Lisa E.
dc.contributor.authorKillilea, Marykate
dc.contributor.authorHughes, Edel M.
dc.contributor.authorCorcoran, Louise
dc.contributor.authorFinn, David P.
dc.contributor.authorRoche, Michelle
dc.date.accessioned2020-01-13T11:12:04Z
dc.date.available2020-01-13T11:12:04Z
dc.date.issued2017-02-22
dc.identifier.citationHenry, Rebecca J., Kerr, Daniel M., Flannery, Lisa E., Killilea, Marykate, Hughes, Edel M., Corcoran, Louise, Finn, David P., Roche, Michelle. (2017). Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1. Brain, Behavior, and Immunity, 62, 318-331. doi: https://doi.org/10.1016/j.bbi.2017.02.016en_IE
dc.identifier.issn1090-2139
dc.identifier.urihttp://hdl.handle.net/10379/15695
dc.description.abstractAberrant activation of toll-like receptors (TLRs), key components of the innate immune system, has been proposed to underlie and exacerbate a range of central nervous system disorders. Increasing evidence supports a role for the endocannabinoid system in modulating inflammatory responses including those mediated by TLRs, and thus this system may provide an important treatment target for neuroinflammatory disorders. However, the effect of modulating endocannabinoid tone on TLR-induced neuroinflammation in vivo and associated behavioural changes is largely unknown. The present study examined the effect of inhibiting fatty acid amide hydrolyase (FAAH), the primary enzyme responsible for the metabolism of anandamide (AEA), in vivo on TLR4-induced neuroimmune and behavioural responses, and evaluated sites and mechanisms of action. Systemic administration of the FAAH inhibitor PF3845 increased levels of AEA, and related FAAH substrates N-oleoylethanolamide (OEA) and N-palmitoylethanolamide (PEA), in the frontal cortex and hippocampus of rats, an effect associated with an attenuation in the expression of pro-and anti-inflammatory cytokines and mediators measured 2hrs following systemic administration of the TLR4 agonist, lipopolysaccharide (LPS). These effects were mimicked by central i. c.v. administration of PF3845, but not systemic administration of the peripherally -restricted FAAH inhibitor URB937. Central antagonism of TRPV1 significantly attenuated the PF3845-induced decrease in IL-6 expression, effects not observed following antagonism of CB1, CB2, PPAR alpha, PPAR gamma or GPR55. LPS-induced a robust sickness -like behavioural response and increased the expression of markers of glial activity and pro-inflammatory cytokines over 24hrs. Systemic administration of PF3845 modulated the TLR4-induced expression of neuroimmune mediators and anhedonia without altering acute sickness behaviour. Overall, these findings support an important role for FAAH substrates directly within the brain in the regulation of TLR4-associated neuroinflammation and highlight a role for TRPV1 in partially mediating these effects.(C) 2017 Elsevier Inc. All rights reserved.en_IE
dc.description.sponsorshipThe authors would like to gratefully acknowledge funding received from the Science Foundation Ireland Research Frontiers Programme (Grant no. 11/RFP/NES/3175), The Research Office and College of medicine, Nursing and Health Sciences National University of Ireland Galway. The authors would also like to thank Patricia Calcagno for technical assistance during this study.en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherElsevieren_IE
dc.relation.ispartofBrain Behavior And Immunityen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectToll-like receptorsen_IE
dc.subjectAnandamideen_IE
dc.subjectCytokinesen_IE
dc.subjectNeuroinflammationen_IE
dc.subjectSicknessen_IE
dc.subjectAnhedoniaen_IE
dc.subjectFEAR-CONDITIONED ANALGESIAen_IE
dc.subjectINNATE IMMUNE-RESPONSEen_IE
dc.subjectENDOCANNABINOID SYSTEMen_IE
dc.subjectRAT MODELen_IE
dc.subjectTNF-ALPHAen_IE
dc.subjectCB2 RECEPTORSen_IE
dc.subjectNITRIC-OXIDEen_IE
dc.subjectANANDAMIDEen_IE
dc.subjectPAINen_IE
dc.subjectINFLAMMATIONen_IE
dc.titlePharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1en_IE
dc.typeArticleen_IE
dc.date.updated2020-01-10T10:30:42Z
dc.identifier.doi10.1016/j.bbi.2017.02.016
dc.local.publishedsourcehttps://doi.org/10.1016/j.bbi.2017.02.016en_IE
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funderScience Foundation Irelanden_IE
dc.contributor.funderResearch Office, National University of Ireland Galwayen_IE
dc.contributor.funderCollege of Medicine, Nursing and Health Sciences, National University of Ireland Galwayen_IE
dc.internal.rssid12518191
dc.local.contactMichelle Roche, Physiology, Rm2002 Human Biology Building, National University Of Ireland G, University Road. 5427 Email: michelle.roche@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionACCEPTED
dcterms.projectinfo:eu-repo/grantAgreement/SFI/SFI Research Frontiers Programme (RFP)/11/RFP.1/NES/3175/IE/Endocannabinoid regulation of neuroinflammatory responses following bacterial and viral infection/en_IE
nui.item.downloads455


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland